These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 20430224

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP.
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
    Gabr A, Abouchaleh N, Ali R, Vouche M, Atassi R, Memon K, Asadi AA, Baker T, Caicedo JC, Desai K, Fryer J, Hickey R, Abeccassis M, Habib A, Hohlastos E, Ganger D, Kulik L, Lewandowski RJ, Riaz A, Salem R.
    Eur J Radiol; 2017 Aug; 93():100-106. PubMed ID: 28668402
    [Abstract] [Full Text] [Related]

  • 4. Downstaging of bilobar hepatocellular carcinoma after radioembolization with 90Y microspheres as a bridge to liver transplantation.
    Reguera-Berenguer L, Orcajo-Rincón J, Rotger-Regí A, Matilla-Peña AM, Echenagusia-Boyra M, Pérez-Pascual R, Marí-Hualde A, Alonso-Farto JC.
    Rev Esp Med Nucl Imagen Mol; 2017 Aug; 36(5):329-332. PubMed ID: 28268101
    [Abstract] [Full Text] [Related]

  • 5. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
    Ettorre GM, Levi Sandri GB, Laurenzi A, Colasanti M, Meniconi RL, Lionetti R, Santoro R, Lepiane P, Sciuto R, Pizzi G, Cianni R, Golfieri R, D'Offizi G, Pellicelli AM, Antonini M, Vennarecci G.
    World J Surg; 2017 Jan; 41(1):241-249. PubMed ID: 27495316
    [Abstract] [Full Text] [Related]

  • 6. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
    Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA, Abecassis MM, Haines KG, Salem R.
    J Surg Oncol; 2006 Dec 01; 94(7):572-86. PubMed ID: 17048240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S, Sukato D, Chen HW, Amesur N, Zajko AB, Humar A, Geller DA, Marsh JW, Tsung A.
    J Vasc Interv Radiol; 2013 Nov 01; 24(11):1632-8. PubMed ID: 24160821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB.
    Ann Surg; 2008 Oct 01; 248(4):617-25. PubMed ID: 18936575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.
    Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS.
    J Gastrointest Surg; 2006 Mar 01; 10(3):413-6. PubMed ID: 16504888
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.
    Ali R, Riaz A, Gabr A, Abouchaleh N, Mora R, Al Asadi A, Caicedo JC, Abecassis M, Katariya N, Maddur H, Kulik L, Lewandowski RJ, Salem R.
    Eur J Nucl Med Mol Imaging; 2017 Dec 01; 44(13):2195-2202. PubMed ID: 28812136
    [Abstract] [Full Text] [Related]

  • 15. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.
    Ibrahim SM, Kulik L, Baker T, Ryu RK, Mulcahy MF, Abecassis M, Salem R, Lewandowski RJ.
    Cardiovasc Intervent Radiol; 2012 Oct 01; 35(5):1094-101. PubMed ID: 22069121
    [Abstract] [Full Text] [Related]

  • 16. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, Mulcahy MF, Baker T, Abecassis M, Miller FH, Yaghmai V, Sato K, Desai K, Thornburg B, Benson AB, Rademaker A, Ganger D, Kulik L, Lewandowski RJ.
    Gastroenterology; 2016 Dec 01; 151(6):1155-1163.e2. PubMed ID: 27575820
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC, Mente ED, Castro-e-Silva O, Sankarankutty AK, Cantão CA, Souza FF, Abud D, Muglia V, Elias-Junior J, Martinelli AL.
    Transplant Proc; 2010 Mar 01; 42(2):502-4. PubMed ID: 20304177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma.
    Kulik L, Vouche M, Koppe S, Lewandowski RJ, Mulcahy MF, Ganger D, Habib A, Karp J, Al-Saden P, Lacouture M, Cotliar J, Abecassis M, Baker T, Salem R.
    J Hepatol; 2014 Aug 01; 61(2):309-17. PubMed ID: 24681342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.